Loading...
Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
BACKGROUND: It is well known that human clear cell renal cell carcinoma (ccRCC) is a highly immunogenic and chemo-resistant tumor. Recently, emerging data suggest that the immune checkpoint blockade therapy is an important breakthrough in the treatment against ccRCC. HHLA2, a recently reported membe...
Na minha lista:
| Udgivet i: | Cancer Cell Int |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6469208/ https://ncbi.nlm.nih.gov/pubmed/31015801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0813-2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|